Patient-reported outcomes of ocriplasmin for the treatment of vitreomacular traction: a systematic review and synthesis of the literature

References

• DukerJSKaiserPKBinderSThe International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular holeOphthalmology2013120122611261924053995
   PubMed Web of Science ®Google Scholar
• JacksonTLDonachiePHJohnstonRLVitreomacular Traction Study GroupElectronic medical record database study of vitrectomy and observation for vitreomacular tractionRetina201636101897190526966869
   PubMed Web of Science ®Google Scholar
• BottósJMElizaldeJRodriguesEBMaiaMCurrent concepts in vitreomacular traction syndromeCurr Opin Ophthalmol201223319520122450220
   PubMed Web of Science ®Google Scholar
• JacksonTLRegilloCDGirachADugelPUMIVI-TRUST Study GroupBaseline predictors of vitreomacular adhesion/traction resolution following an intravitreal injection of ocriplasminOphthalmic Surg Lasers Imaging Retina201647871672327548448
   PubMed Web of Science ®Google Scholar
• DennistonAKKyteDCalvertMBurrJMAn introduction to patient-reported outcome measures in ophthalmic researchEye201428663764524625379
   PubMed Web of Science ®Google Scholar
• JohnsonMWPosterior vitreous detachment: evolution and complications of its early stagesAm J Ophthalmol20101493371382.e120172065
   PubMed Web of Science ®Google Scholar
• TannerVChauhanDSJacksonTLWilliamsonTHOptical coherence tomography of the vitreoretinal interface in macular hole formationBr J Ophthalmol20018591092109711520763
   PubMed Web of Science ®Google Scholar
• ChauhanDSAntcliffRJRaiPAWilliamsonTHMarshallJPapillofoveal traction in macular hole formation: the role of optical coherence tomographyArch Ophthalmol20001181323810636411
   PubMedGoogle Scholar
• WickströmKMoseleyJBiomarkers and surrogate endpoints in drug development: a European regulatory viewInvest Ophthalmol Vis Sci2017586BIO27BIO3328475700
   PubMed Web of Science ®Google Scholar
• JacksonTLNicodESimpsonAAngelisAGrimacciaFKanavosPSymptomatic vitreomacular adhesionRetina20133381503151123714857
   PubMed Web of Science ®Google Scholar
• StalmansPBenzMSGandorferAEnzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holesN Engl J Med2012367760661522894573
   PubMed Web of Science ®Google Scholar
• DugelPUTolentinoMFeinerLKozmaPLeroyAResults of the 2-year ocriplasmin for treatment for symptomatic vitreomacular adhesion including macular hole (OASIS) randomized trialOphthalmology2016123102232224727499517
   PubMed Web of Science ®Google Scholar
• PatelPJSteelDHHirneißCPatient-reported prevalence of metamorphopsia and predictors of vision-related quality of life in vit-reomacular traction: a prospective, multicentre studyEye2018120
   Google Scholar
• NeffendorfJESimpsonARHSteelDHWIntravitreal gas for symptomatic vitreomacular adhesion: a synthesis of the literatureActa Ophthalmol201896768569128857483
   PubMed Web of Science ®Google Scholar
• American Academy of Ophthalmology Retina/Vitreous PanelPreferred Practice Pattern® GuidelinesIdiopathic macular holeSan Francisco, CAAmerican Academy of Ophthalmology2014 updated 2017133 Available from: www.aao.org/pppAccessed October 3, 2018
   Google Scholar
• NeffendorfJEKirthiVPringleEJacksonTLOcriplasmin for symptomatic vitreomacular adhesionCochrane Database Syst Rev201710CD011874
   Google Scholar
• NICEGuide to the methods of technology appraisal201320131102 https://www.nice.org.uk/process/pmg9/chapter/foreword#.XHLCLhw-mi6I.email
   Google Scholar
• FolkJCAdelmanRAFlaxelCJHymanLPulidoJSOlsenTWIdiopathic Epiretinal Membrane and Vitreomacular Traction Preferred Practice Pattern® GuidelinesOphthalmology20161231P152P18126578445
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Services Food and Drug AdministrationGuidance for industry2009143
   Google Scholar
• Prem SenthilMKhadkaJPesudovsKAssessment of patient-reported outcomes in retinal diseases: a systematic reviewSurv Ophthalmol201762454658228062197
   PubMed Web of Science ®Google Scholar
• PaisleySBoothAMensinkaiSHealth-related quality of life studiesEtext on Health Technology Assessment (HTA) information resourcesBethesda, MDUS National Library of Medicine (NLM), National Information Center on Health Services Research and Healthcare Technology (NICHSR)2005
   Google Scholar
• AraRBrazierJPeasgoodTPaisleySThe identification, review and synthesis of health state utility values from the literaturePharmacoeconomics201735Suppl 14355
   PubMed Web of Science ®Google Scholar
• GandorferABenzMSHallerJAAssociation between anatomical resolution and functional outcomes in the MIVI-TRUST studies using ocriplasmin to treat symptomatic vitreomacular adhesion/vitreo-macular traction, including when associated with macular holeRetina20153561151115725741816
   PubMed Web of Science ®Google Scholar
• MangioneCMLeePPGutierrezPRDevelopment of the 25-list-item National Eye Institute visual function questionnaireArch Ophthalmol200111971050105811448327
   PubMed Web of Science ®Google Scholar
• RAND CThe National Eye Institute 25-item visual function questionnaire (VFQ-25)2000115 Available from: https://www.rand.org/health-care/surveys_tools/vfq.htmlAccessed October 3, 2018
   Google Scholar
• JacksonTLVerstraetenTDuchateauLLescrauwaetBVisual function response to ocriplasmin for the treatment of vitreomacular traction and macular holeActa Ophthalmol2017958e740e74528133919
   PubMed Web of Science ®Google Scholar
• JolliffeIPrincipal Component AnalysisChichester, UKJohn Wiley & Sons, Ltd2014
   Google Scholar
• DerSimonianRLairdNMeta-analysis in clinical trialsControl Clin Trials1986731771883802833
   PubMedGoogle Scholar
• VarmaRHallerJAKaiserPKImprovement in patient-reported visual function after Ocriplasmin for Vitreomacular adhesion: results of the microplasmin for intravitreous injection-traction release without surgical treatment (MIVI-TRUST) trialsJAMA Ophthalmol20151339997100426068086
   PubMed Web of Science ®Google Scholar
• LescrauwaetBDuchateauLVerstraetenTJacksonTLVisual function response to ocriplasmin for the treatment of vitreomacular traction and macular hole: the OASIS studyInvest Ophthalmol Vis Sci201758135842584829141079
   PubMed Web of Science ®Google Scholar
• GuyattGHThorlundKOxmanADGgHGrade guidelines: 13. Preparing summary of findings tables and evidence profiles-continuous outcomesJ Clin Epidemiol201366217318323116689
   PubMed Web of Science ®Google Scholar
• DeanSMathersJMCalvertM“The patient is speaking”: discovering the patient voice in ophthalmologyBr J Ophthalmol2017101670070828455280
   PubMed Web of Science ®Google Scholar
• WickströmKMoseleyJBiomarkers and surrogate endpoints in drug development: a European regulatory viewInvest Ophthalmol Vis Sci2017586BIO27BIO3328475700
   PubMed Web of Science ®Google Scholar
• LongworthLYangYYoungTUse of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and surveyHealth Technol Assess20141891224
   PubMed Web of Science ®Google Scholar
• ToshJBrazierJEvansPLongworthLA review of generic preference-based measures of health-related quality of life in visual disordersValue Health201215111812722264979
   PubMed Web of Science ®Google Scholar
• NaikRKGriesKSRentzAMKowalskiJWRevickiDAPsychometric evaluation of the National Eye Institute visual function questionnaire and visual function questionnaire utility index in patients with non-infectious intermediate and posterior uveitisQual Life Res201322102801280823645458
   PubMed Web of Science ®Google Scholar
• FrickKDDryeLTKempenJHAssociations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trialInvest Ophthalmol Vis Sci20125331169117622247489
   PubMed Web of Science ®Google Scholar
• LundströmMWendelEAssessment of vision-related quality of life measures in ophthalmic conditionsExpert Rev Pharmacoecon Outcomes Res20066669172420528495
   PubMedGoogle Scholar
• PatrickDLBurkeLBPowersJHPatient-reported outcomes to support medical product labeling claims: FDA perspectiveValue Health200710Suppl 2S125S13717995471
   PubMed Web of Science ®Google Scholar
• PaulCKrugPMüllerHHComparison of the horizontal diameter to a modeled area of traction in eyes with vitreomacular traction: is the diameter close enough to the truth?Graefes Arch Clin Exp Ophthalmol2018256101817182229955972
   PubMed Web of Science ®Google Scholar
• PesudovsKGothwalVKWrightTLamoureuxELRemediating serious flaws in the National Eye Institute visual function questionnaireJ Cataract Refract Surg201036571873220457362
   PubMed Web of Science ®Google Scholar
• DoughertyBEBullimoreMAComparison of scoring approaches for the NEI VFQ-25 in low visionOptom Vis Sci201087854354820526224
   PubMed Web of Science ®Google Scholar